Reliability and validity of a Norwegian version of the Quality of Life in Epilepsy Inventory (QOLIE-89)

Epilepsia

Volumn 41, Issue 1, 2000, Pages 91-97

  Stavem, Knut ^a   Bjørnæs, Helge ^b   Lossius, Morten I ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b National Center for Epilepsy   (Norway)

Author keywords

Construct validity; Epilepsy; Health status; Health related quality of life; Quality of life in epilepsy inventory

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; VALIDATION PROCESS;

EID: 0033989092     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb01511.x     Document Type: Article

References (22)

1. Vickrey BG, Hays RD, Graber J, Rausch R, Engel J Jr, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care 1992;30:299-319.
2. Vickrey B, Perrine KR, Hays RD, et al. Scoring manual for the Quality of Life in Epilepsy inventory-89 (QOLIE-89). Santa Monica, CA: Rand, 1993.
3. Perrine K, Hermann BP, Meador KJ, et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995;52:997-1003.
4. Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res 1993;16:65-81.
5. Baker GA. Health-related quality-of-life issues: optimizing patient outcomes. Neurology 1995;45:S29-34.
6. Devinsky O, Cramer JA. Introduction: quality of life in epilepsy. Epilepsia 1993;34(suppl 4):S1-3.
7. Devinsky O, Vickrey BG, Cramer J, et al. Development of the Quality of Life in Epilepsy inventory. Epilepsia 1995;36:1089-104.
8. Devinsky O. Clinical uses of the Quality-of-Life in Epilepsy inventory. Epilepsia 1993;34(suppl 4):S39-44.
9. Kline Leidy N, Rentz AM, Grace EM. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia 1998;39:965-77.
10. Cramer JA, Perrine K, Devinsky O, Bryant-Comslock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998;39: 81-8.
11. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
12. Ware JE Jr, Snow KK, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
13. Petersen B, Walker ML, Runge U, Kessler C. Quality of life in patients with idiopathic, generalized epilepsy. J Epilepsy 1998;11: 306-13.
14. Sintonen H. A fifteen-dimensional measure of health-related quality of life (15D) and its applications. In: Walker SR, Rosser R, eds. Quality of life assessment: key issues in the 1990s. Dordrecht: Kluwer Academic Publishers, 1993:185-95.
15. Sintonen, H. The 15D-measure of health-related quality of life: I: reliability, validity and sensitivity of its health state descriptive system: working paper 41. Melbourne, Australia: National Centre for Health Program Evaluation, 1994.
16. Sintonen, H. The 15D-measure of health-related quality of life. II: feasibility, reliability and validity of its valuation system: working paper 42. Melbourne, Australia: National Centre for Health Program Evaluation, 1994.
17. Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res 1998;29:201-9.
18. Aaronson NK, Acquadro C, Alonso J, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992;1:349-51.
19. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrica 1951;16:297-334.
20. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994.
21. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991;12:142S-58S.
22. Wagner AK, Keller SD, Kosinski M, et al. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Qual Life Res 1995;4: 115-34.